MEKTOVI (BINIMETINIB) Trademark

Trademark Overview


On Friday, June 3, 2016, a trademark application was filed for MEKTOVI (BINIMETINIB) with the United States Patent and Trademark Office. The USPTO has given the MEKTOVI (BINIMETINIB) trademark a serial number of 87059929. The federal status of this trademark filing is REGISTERED as of Tuesday, January 16, 2018. This trademark is owned by Array Biopharma Inc.. The MEKTOVI (BINIMETINIB) trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharma...
mektovi (binimetinib)

General Information


Serial Number87059929
Word MarkMEKTOVI (BINIMETINIB)
Filing DateFriday, June 3, 2016
Status700 - REGISTERED
Status DateTuesday, January 16, 2018
Registration Number5381495
Registration DateTuesday, January 16, 2018
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 4, 2017

Trademark Statements


Description of MarkThe mark consists of the words "MEKTOVI" and below "MEKTOVI" in smaller lettering is the word "(binimetinib)". The upper right of "MEKTOVI" is a series of overlapping circles arranged in a horizontal manner.
Goods and ServicesAnti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer and tumors; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; all of the foregoing incorporating the inhibitor binimetinib
Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"BINIMETINIB"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 10, 2016
Primary Code005
First Use Anywhere DateThursday, September 21, 2017
First Use In Commerce DateThursday, September 21, 2017

Trademark Owner History


Party NameArray Biopharma Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBoulder, CO 80301

Party NameArray Biopharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoulder, CO 80301

Party NameArray Biopharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoulder, CO 80301

Trademark Events


Event DateEvent Description
Monday, January 16, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, June 4, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 4, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 4, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 4, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 4, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 16, 2018REGISTERED-PRINCIPAL REGISTER
Saturday, December 9, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, December 8, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, December 7, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 6, 2017EXAMINER'S AMENDMENT ENTERED
Wednesday, December 6, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, December 6, 2017EXAMINERS AMENDMENT E-MAILED
Wednesday, December 6, 2017SU-EXAMINER'S AMENDMENT WRITTEN
Wednesday, December 6, 2017STATEMENT OF USE PROCESSING COMPLETE
Thursday, November 30, 2017USE AMENDMENT FILED
Wednesday, December 6, 2017SOU EXTENSION 1 GRANTED
Thursday, November 30, 2017SOU EXTENSION 1 FILED
Wednesday, December 6, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, November 30, 2017SOU TEAS EXTENSION RECEIVED
Thursday, November 30, 2017TEAS STATEMENT OF USE RECEIVED
Tuesday, May 30, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 4, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 4, 2017PUBLISHED FOR OPPOSITION
Wednesday, March 15, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 28, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 22, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 22, 2017EXAMINER'S AMENDMENT ENTERED
Wednesday, February 22, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, February 22, 2017EXAMINERS AMENDMENT E-MAILED
Wednesday, February 22, 2017EXAMINERS AMENDMENT -WRITTEN
Wednesday, February 15, 2017PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, November 14, 2016WITHDRAWN FROM PUB - MANAGING ATTORNEY REQUEST
Friday, November 4, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, October 28, 2016ASSIGNED TO LIE
Friday, October 14, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 14, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 13, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 13, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 16, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 16, 2016NON-FINAL ACTION E-MAILED
Friday, September 16, 2016NON-FINAL ACTION WRITTEN
Thursday, September 15, 2016ASSIGNED TO EXAMINER
Saturday, June 11, 2016NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, June 10, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 7, 2016NEW APPLICATION ENTERED